Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Notice of Intent to Publish a Funding Opportunity…

U.S. National Institutes of Health·United States of America

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)

Rolling / TBD close$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) for the Blueprint MedTech program, which will support the development of human-grade medical device prototypes. The program aims to prepare projects for first-in-human testing via other FOAs within the BP MedTech program. The FOA is expected to be published in Summer 2021 with an expected application due date in Fall 2021. • The FOA will utilize the U18 activity code. • The program will support development of human-grade medical device prototypes. • Projects will complete product definition and development, including needs assessment, product design, prototype development, and bench testing. • The end goal is to prepare for first-in-human testing via other FOAs within the BP MedTech program. • Eligible applicants include for-profit organizations, independent school districts, private institutions of higher education, county governments, and others.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Michael Wolfson

[email protected]

(301) 451-6987

Key dates

Opened
5/28/2021
Closes
Rolling / TBD
Projected award
6/1/2022

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
339112
Solicitation №
NOT-EB-21-018

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is not explicitly stated in the document. However, based on the fact that it is a grant for the development of human-grade medical device prototypes, we can estimate that the budget could be in the range of $500,000 to $2 million. This is a rough estimate and may vary depending on the specific requirements of the project and the number of applicants. The actual budget may be influenced by factors such as the complexity of the project, the experience and qualifications of the applicant, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 76%

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Closes 9/7/2027Opened 3/8/2022

U.S. National Institutes of Health·United States of America

76% match

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Closes 1/28/2028Opened 5/5/2025

U.S. National Institutes of Health·United States of America

75% match

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/21/2022

U.S. National Institutes of Health·United States of America

75% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. National Institutes of Health·United States of America

74% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. National Institutes of Health·United States of America

74% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

74% match

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closes 8/18/2027Opened 10/1/2024

U.S. National Institutes of Health·United States of America

74% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

73% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

73% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

73% match

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

73% match

Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources (S15 Clinical Trial Not Allowed)

Closes 9/26/2027Opened 8/24/2026

U.S. National Institutes of Health·United States of America

73% match

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

73% match

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Closes 1/7/2028Opened 5/10/2022

U.S. National Institutes of Health·United States of America

73% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

73% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 1/11/2022

U.S. National Institutes of Health·United States of America

73% match

Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

Closes 11/10/2026Opened 6/25/2026

U.S. National Institutes of Health·United States of America

73% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

72% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

72% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

72% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024

U.S. National Institutes of Health·United States of America

72% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. Food and Drug Administration·United States of America

72% match

Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. Food and Drug Administration·United States of America

72% match

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 12/12/2023